Document Detail

Severe myocarditis and esophagitis during reversible long standing Chagas' disease recrudescence in immunocompromised host.
MedLine Citation:
PMID:  7649674     Owner:  NLM     Status:  MEDLINE    
An unusual form of reagudization of Chagas' disease, from its indeterminate phase, was documented in an immunocompromised patient. Long-standing progressive visceral aggression due to extensive intracellular proliferation of T. cruzi manifested by severe isolated right ventricular failure and esophageal ulcerations. Antiparasite chemotherapy was effective in the control of the disease.
M V Simões; F A Soares; J A Marin-Neto
Related Documents :
20450304 - Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.
19923744 - Crystallization and preliminary crystallographic studies of dihydrofolate reductase-thy...
10725904 - Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?
10717744 - Evaluation of a synthetic tripeptide as antigen for detection of igm and igg antibodies...
17653124 - Mechanisms of disease: what can mouse models tell us about the molecular processes unde...
23575334 - Genotyping of mycobacterium intracellulare isolates and clinical characteristics of lun...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  International journal of cardiology     Volume:  49     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-09-25     Completed Date:  1995-09-25     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  271-3     Citation Subset:  IM    
Cardiology Division of Medical School of Ribeirão Preto, University of São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chagas Cardiomyopathy / complications*,  drug therapy,  ultrasonography
Esophagitis / complications*,  pathology
Immunocompromised Host*
Nitroimidazoles / therapeutic use
Trypanocidal Agents / therapeutic use
Reg. No./Substance:
0/Nitroimidazoles; 0/Trypanocidal Agents; 22994-85-0/benzonidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size est...
Next Document:  Sudden death in mitral valve prolapse with Holter monitoring-documented ventricular fibrillation: ev...